Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : InvestRight Club Challenge -- Ignore unavailable to you. Want to Upgrade?

To: Jeffrey L. Henken who wrote (1801)	5/4/1999 1:21:00 PM
From: Bruce Cullen	Read Replies (1) \| Respond to of 2662

Jeff take a look at this and let me know your thoughts, seriously? Jeff I think ORG has the product here and backed by Novartis global. Bruce ---------- Ascending triangle pattern... ORG chart is looking explosive, we look ready to pull out of a triangle pattern any moment, all indicators are pointing up and the news out today support my claims on ORG I have had for over 1 year now at SCG. The numbers of sales at ORG is positive, the % change in orders is perfect for continued interest to come into this stock. The market is just not in favor of the sector at the moment. With a 50 day and 200 day avg ready to cross on ORG be ready for a series of volatility and most of it to be on upside swings. The short position that seems to be ignoring the sales increases and trying to convince you that ORG has nothing in the pipeline is bogus. I suggest you call ORG for yourself and ask them what they have in the pipeline. You just may find the reality to my findings here. In my opinion!--> ATIS bashers are stressed over the possibility that ATIS may again fail in it's attempts for FDA approval, remember that the reasons that ATIS was refused the last time. If ATIS does not win over the FDA this time I feel they are going to find themselves cash starved & possibly chap. 11 later. Knowing how these stock plummet after they even get FDA approvals is another thorn in the skin at ATIS' potential as an investment. (Again it's all my opinion only!) Bruce SCG geocities.com -------------------